The novel therapy of the medication represents a exciting advance in the handling of diabetes mellitus type 2. Distinct from existing therapies, tirzepatide affects multiple pathways – glucagon-like peptide-1 (GLP-1) https://tirzepatidepeptide960994.jts-blog.com/40580394/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment